Keywords
Glycated albumin
Diabetic nephropathy
Dialysis
Submitted : 2024-08-27
Accepted : 2024-09-11
Published : 2024-09-26
Abstract
Objective: To explore the clinical application of nutritional management combined with clinical monitoring of glycated albumin (GA) in diabetic nephropathy (DN) dialysis patients. Methods: A total of 20 diabetic nephropathy dialysis patients admitted to the People’s Hospital of Guandu District from January 2022 to February 2023 were included in the study. They were randomly divided into a conventional group (n = 10) and an observation group (n = 10). The study evaluated the blood glucose control, nutritional status, dialysis efficacy, and quality of life scores of both groups. Results: Before the intervention, there were no significant differences in fasting plasma glucose (FPG), GA, serum albumin, body mass index (BMI), dialysis efficiency values, urea clearance rate, or quality-of-life scores between the two groups (P > 0.05). After the intervention, the observation group showed significantly lower FPG and GA levels, higher serum albumin, dialysis efficiency values, urea clearance rate, and improved quality-of-life scores compared to the conventional group (P < 0.05), with no difference in BMI (P > 0.05). Conclusion: Nutritional management combined with clinical monitoring of glycated albumin has a significant effect on the clinical application of diabetic nephropathy dialysis patients. It can effectively improve patients’ blood glucose control and nutritional status, reduce the risk of complications, and enhance the quality of life, demonstrating clinical value for broader application.
References
Li T, Yu X, Ma X, et al., 2023, Effects of Citrulline on Renal Injury and Skeletal Muscle Atrophy in Diabetic Nephropathy Mice. Acta Nutrimenta Sinica, 45(5): 441–447.
Fu Y, 2018, Nutritional Status of Diabetic Nephropathy Patients and Its Correlation with Serum Cystatin C Levels. Chinese Journal of Gerontology, 38(9): 3.
Lou Q, Chen Z, Jiang Q, et al., 2018, Research Progress on the Mechanism, Diagnosis, and Treatment of Elderly Diabetic Nephropathy. Chinese Journal of Gerontology, 38(1): 4.
Fei Y, Sheng X, Chen T, et al., 2018, The Value of Corrected Glycated Albumin in Assessing Blood Glucose in Diabetic Nephropathy Patients with Massive Proteinuria. Shanghai Medical Journal, 41(2): 5.
Multidisciplinary Expert Group on the Diagnosis and Management of Diabetic Nephropathy, 2020, Multidisciplinary Consensus of Diagnosis and Management of Diabetic Nephropathy. Chinese Journal of Clinical Physicians, 48(5): 522–527.
Zhang D, Li Q, 2020, Clinical Application Progress of the Glycated Albumin-to-Glycated Hemoglobin Ratio. Chinese General Practice, 23(17): 5.
Li X, Wang H, Fan Q, et al., 2018, Changes and Significance of Serum microRNA-148b-3p Levels in Patients with Type 2 Diabetes and Diabetic Nephropathy. Chinese Journal of Nephrology, 34(5): 7.
Dong K, 2023, Discussion on the Clinical Significance of Detecting Glycated Hemoglobin and Urinary Microalbumin in Early Diabetic Nephropathy. Smart Healthcare, 9(12): 9–12.
Yu S, Zeng X, Fu P, 2023, Integrated Management Improves Quality of Life in a Diabetic Nephropathy Hemodialysis Patient: A Case Report. Chinese Journal of Nephrology, 39(4): 291–293.
Sang L, Zhang S, Zhang Y, 2023, Application Value of High-Sensitivity C-Reactive Protein, Urinary Microalbumin, and Whole Blood Glycated Hemoglobin Combined Detection in Early Diabetic Nephropathy. Diabetes New World, 26(3): 30–34.
Bai J, Liu Y, Wang X, 2018, Study on the Correlation Between Glycated Albumin and Related Metabolic Indicators and Early Renal Function Damage in Type 2 Diabetes. Chinese Journal of New Drugs, 27(16): 1872–1876.